Skip to main content

HB 1796 — New Hampshire

allowing the use of psilocybin in approved clinical settings to treat qualified medical conditions.

Introduced 2026 session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • HB 1796 is a bill in the New Hampshire House, 2026 session, introduced December 17, 2025.
  • Sponsored by Michael Moffett, with 8 cosponsors.
  • Current status: introduced.
  • Most recent action (February 3, 2026): Minority Committee Report: Ought to Pass.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Michael Moffett

Cosponsors (8): Henry Giasson, Jennifer Mandelbaum, Tom Mannion, Carol McGuire, Terry Roy, Matt Sabourin dit Choinière, Howard Pearl, David Watters

History

  1. Introduced, completed
  2. Passed House, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House Introduced 01/07/2026 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 36 Milestone
  2. House Public Hearing: 01/14/2026 02:00 pm GP 158
  3. House Executive Session: 01/28/2026 02:30 pm GP 158
  4. House Majority Committee Report: Inexpedient to Legislate 01/28/2026 (Vote 11-7; RC) HC 10 P. 91
  5. House Minority Committee Report: Ought to Pass Latest

Source: Open States. Last checked November 13, 2026. How we keep this accurate ›